Lizzie Fletcher

Not analysed yet

A requested analysis is usually ready within half an hour; come back to this page or reload it.

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 8005. This legislation addresses the supply chains that turn illicit chemicals into counterfeit pills by targeting the equipment, importation, and production behind the fentanyl crisis. Over the past several years, we have worked together in a strong, bipartisan way to make real progress in combating the overdose crisis. However, it is important to recognize that an enforcement-only strategy is not the answer. This legislation prioritizes enforcement, and enforcement alone ultimately does not save lives. The good news is that we know what does: expanding access to treatment for opioid use disorder and harm-reduction interventions like fentanyl test strips and naloxone. That is why the Trump administration's actions to slash substance use treatment funding is so alarming. It could threaten the real progress that we have made. The Trump administration has dismantled the Substance Abuse and Mental Health Services Administration, SAMHSA, the agency responsible for addressing the overdose crisis, and it has kept hundreds of millions of dollars in addiction and overdose prevention funding. If we truly want to protect our community, we need to work together to increase access to treatment and stop these attacks from this administration. Mr. Speaker, I reserve the balance of my time.